Lobbying Strategy in Europe: Vitamin, or Painkiller?

Lobbying Strategy in Europe Vitamin or Painkiller

 

When a startup pitches their business to a venture capitalist to finance it, usually there is a question the potential investor will ask them:

 

is your company a vitamin or a painkiller?

 

That’s a very good question also when we talk about lobbying and the specific issue that you or your company are advocating: is your position a vitamin or a painkiller for the policy-maker.

 

A vitamin means that it enhances their status, it gives them more visibility,
it helps them look better in the eyes of voters or their peers

 

A painkiller, on the other hand, is something that could, for instance, help them avoid the loss of jobs, or avoid the banning of a certain substance or material. So that’s more about damage control.

 

The two narratives are vastly different because advocating
for a vitamin is a very positive narrative

 

that is easy to sell and inspires anyone who is dealing with that particular policy.

 

Whereas advocating for a painkiller is often more defensive and is harder to sell and harder to convince policy-makers about it.

 

What companies often forget is that the
very same issue can be packaged either way.

 

If you manage to turn that painkiller into a vitamin and present it to a member of the European Parliament or a national legislation, suddenly it will trigger a very different reception and a much better outcome in terms of your policy goal.

 

See video: https://youtu.be/Kj6A-Znfj84

 

Posted in Public Affairs

Leave a Reply

Copyright © Andras Baneth. All Rights Reserved.